Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell (Q68259067)
scientific article published on 01 July 1991
Language:
Current Data About Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell
(P31) (Q13442814)
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P304) 42-47
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P407) (Q1860)

(P433) 1
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P478) 30
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P577) Monday, July 1, 1991
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P921) (Q8277)
(P887)

(P1433) (Q564414)
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P1476) "Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell" (language: en)
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

(P2093) J W Karaszewski
(P1545) 1
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

A T Reder
(P1545) 2
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

B Anlar
(P1545) 3
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

W C Kim
(P1545) 4
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

B G Arnason
(P1545) 5
(P248)
(P698) 1656847
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1656847%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 23, 2019

other details
description scientific article published on 01 July 1991

External Links
(P356) 10.1002/ANA.410300109
(P698) 1656847